%ΔSUVmax is a Better Predictor of Outcome than Deauville 5-PS after One Cycle of Therapy in Diffuse Large B-Cell Lymphoma (DLBCL)

Autor: Rydzinski, Y., Hutchings, M., Knight-Greenfield, A., Juul Mylam, Karen, Stern, J., Doucette, J., Coleman, M., Kostakaglu, L.

Publikováno v: Rydzinski, Y, Hutchings, M, Knight-Greenfield, A, Juul Mylam, K, Stern, J, Doucette, J, Coleman, M & Kostakaglu, L 2013, ' %ΔSUVmax is a Better Predictor of Outcome than Deauville 5-PS after One Cycle of Therapy in Diffuse Large B-Cell Lymphoma (DLBCL) ', EANM'13 Congress, Lyon, France, 19/10/2013-23/10/2013 .

%ΔSUVmax is a Better Predictor of Outcome than Deauville 5-PS after One Cycle of Therapy in Diffuse Large B-Cell Lymphoma (DLBCL)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::904a6007f9d7e7fcda061b1a0ebc307b
https://portal.findresearcher.sdu.dk/da/publications/79bcca32-82a6-464b-9cb9-d21f358c194c

%Delta SUVmax is a Better Predictor of Outcome than Deauville 5-PS after One Cycle of Therapy in Diffuse Large B- Cell Lymphoma (DLBCL)

Autor: Rydzinski, Y., Martin Hutchings, Knight-Greenfield, A., Mylam, K., Stern, J., Doucette, J., Coleman, M., Kostakaglu, L.

Publikováno v: ResearcherID
Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0fa365e150ae15479e8fcfce10bb77b2
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000325853400327&KeyUID=WOS:000325853400327